Literature DB >> 21752878

Madelung-like deformity in pseudohypoparathyroidism type 1b.

Janine Sanchez1, Erasmo Perera, Suzanne Jan de Beur, Changlin Ding, Anna Dang, Gary D Berkovitz, Michael A Levine.   

Abstract

CONTEXT: Pseudohypoparathyroidism (PHP) types 1a and 1b are distinguished by clinical, biochemical, and molecular features. We report extended kindred with PHP 1b in which many affected members also had growth plate defects, including brachydactyly and a Madelung-like deformity.
DESIGN: Analyses included clinical examination, assessment of mineral metabolism, thyroid function, skeletal radiography, and analysis of the GNAS and STX16 genes.
SETTING: Patients were studied in an academic medical center.
RESULTS: We studied 37 members of a family in which PHP 1b occurred in 23 individuals. Ten of 17 affected patients who were examined had brachydactyly E, including two subjects with Madelung-like defects. Five of 16 subjects had subclinical hypothyroidism; no subject showed sc ossification or short stature. None of the unaffected members had brachydactyly or an elevated serum level of PTH or TSH. Levels of immunoactive erythrocyte Gα(s) were normal in two affected subjects tested. Linkage analysis indicated linkage between PTH resistance and the GNAS gene locus; however, no mutations were identified in GNAS exons 1-13. Methylation analysis of genomic DNA from affected subjects showed loss of maternal epigenotype in exon 1A with normal methylation of the differentially methylated regions for XLGαs and NESP55, and PCR demonstrated heterozygosity for a 3.0-kb deletion in the STX16 gene.
CONCLUSION: The segregation of brachydactyly with PHP 1b in this family indicates that an imprinting defect in GNAS can lead to growth plate defects, including brachydactyly and Madelung deformity. These features suggest that GNAS signaling plays a more extensive role in chondrocyte maturation than previously thought.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21752878      PMCID: PMC3167675          DOI: 10.1210/jc.2011-1411

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  23 in total

1.  Gsα activity is reduced in erythrocyte membranes of patients with psedohypoparathyroidism due to epigenetic alterations at the GNAS locus.

Authors:  Celia Zazo; Susanne Thiele; Cesar Martín; Eduardo Fernandez-Rebollo; Lorea Martinez-Indart; Ralf Werner; Intza Garin; Olaf Hiort; Guiomar Perez de Nanclares
Journal:  J Bone Miner Res       Date:  2011-08       Impact factor: 6.741

2.  Pseudohypoparathyroidism 1b: exclusion of parathyroid hormone and its receptors as candidate disease genes.

Authors:  S M Jan de Beur; C L Ding; M C LaBuda; T B Usdin; M A Levine
Journal:  J Clin Endocrinol Metab       Date:  2000-06       Impact factor: 5.958

3.  PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth.

Authors:  B Lanske; A C Karaplis; K Lee; A Luz; A Vortkamp; A Pirro; M Karperien; L H Defize; C Ho; R C Mulligan; A B Abou-Samra; H Jüppner; G V Segre; H M Kronenberg
Journal:  Science       Date:  1996-08-02       Impact factor: 47.728

4.  Biallelic expression of the Gsalpha gene in human bone and adipose tissue.

Authors:  Giovanna Mantovani; Sara Bondioni; Marco Locatelli; Cecilia Pedroni; Andrea G Lania; Emanuele Ferrante; Marcello Filopanti; Paolo Beck-Peccoz; Anna Spada
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

5.  Completely skewed X-inactivation in a mentally retarded young female with pseudohypoparathyroidism type IB and juvenile renin-dependent hypertension.

Authors:  Masashi Demura; Yoshiyu Takeda; Takashi Yoneda; Kenji Furukawa; Aiko Tachi; Hiroshi Mabuchi
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

6.  Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS.

Authors:  Murat Bastepe; Leopold F Fröhlich; Geoffrey N Hendy; Olafur S Indridason; Robert G Josse; Hiroyuki Koshiyama; Jarmo Körkkö; Jon M Nakamoto; Arlan L Rosenbloom; Arnold H Slyper; Toshitsugu Sugimoto; Agathocles Tsatsoulis; John D Crawford; Harald Jüppner
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

7.  Madelung deformity: surgical prophylaxis (physiolysis) during the late growth period by resection of the dyschondrosteosis lesion.

Authors:  D Vickers; G Nielsen
Journal:  J Hand Surg Br       Date:  1992-08

8.  Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene.

Authors:  A C Karaplis; A Luz; J Glowacki; R T Bronson; V L Tybulewicz; H M Kronenberg; R C Mulligan
Journal:  Genes Dev       Date:  1994-02-01       Impact factor: 11.361

9.  Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia.

Authors:  A S Jobert; P Zhang; A Couvineau; J Bonaventure; J Roume; M Le Merrer; C Silve
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

10.  The pseudohypoparathyroidism type lb locus is linked to a region including GNAS1 at 20q13.3.

Authors:  Suzanne M Jan De Beur; Jeffery R O'Connell; Rita Peila; Justin Cho; Zhichao Deng; Stephen Kam; Michael A Levine
Journal:  J Bone Miner Res       Date:  2003-03       Impact factor: 6.741

View more
  15 in total

1.  A novel deletion involving GNAS exon 1 causes PHP1A and further refines the region required for normal methylation at exon A/B.

Authors:  Monica Reyes; Anara Karaca; Murat Bastepe; Nese Ersoz Gulcelik; Harald Jüppner
Journal:  Bone       Date:  2017-07-12       Impact factor: 4.398

2.  Similar frequency of paternal uniparental disomy involving chromosome 20q (patUPD20q) in Japanese and Caucasian patients affected by sporadic pseudohypoparathyroidism type Ib (sporPHP1B).

Authors:  Rieko Takatani; Masanori Minagawa; Angelo Molinaro; Monica Reyes; Kaori Kinoshita; Tomozumi Takatani; Itsuro Kazukawa; Misako Nagatsuma; Kenichi Kashimada; Kenichi Sato; Kazuyuki Matsushita; Fumio Nomura; Naoki Shimojo; Harald Jüppner
Journal:  Bone       Date:  2015-05-19       Impact factor: 4.398

Review 3.  GNAS Spectrum of Disorders.

Authors:  Serap Turan; Murat Bastepe
Journal:  Curr Osteoporos Rep       Date:  2015-06       Impact factor: 5.096

4.  A Homozygous [Cys25]PTH(1-84) Mutation That Impairs PTH/PTHrP Receptor Activation Defines a Novel Form of Hypoparathyroidism.

Authors:  Sihoon Lee; Michael Mannstadt; Jun Guo; Seul Min Kim; Hyon-Seung Yi; Ashok Khatri; Thomas Dean; Makoto Okazaki; Thomas J Gardella; Harald Jüppner
Journal:  J Bone Miner Res       Date:  2015-06-08       Impact factor: 6.741

5.  A Heterozygous Splice-Site Mutation in PTHLH Causes Autosomal Dominant Shortening of Metacarpals and Metatarsals.

Authors:  Monica Reyes; Bert Bravenboer; Harald Jüppner
Journal:  J Bone Miner Res       Date:  2019-01-02       Impact factor: 6.741

Review 6.  An update on the clinical and molecular characteristics of pseudohypoparathyroidism.

Authors:  Michael A Levine
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-12       Impact factor: 3.243

7.  De novo STX16 deletions: an infrequent cause of pseudohypoparathyroidism type Ib that should be excluded in sporadic cases.

Authors:  Serap Turan; Jaakko Ignatius; Jukka S Moilanen; Outi Kuismin; Helen Stewart; Nicholas P Mann; Agnès Linglart; Murat Bastepe; Harald Jüppner
Journal:  J Clin Endocrinol Metab       Date:  2012-10-18       Impact factor: 5.958

8.  Shortened Fingers and Toes: GNAS Abnormalities are Not the Only Cause.

Authors:  Monica Reyes; Caroline Silve; Harald Jüppner
Journal:  Exp Clin Endocrinol Diabetes       Date:  2019-12-11       Impact factor: 2.949

Review 9.  Molecular Definition of Pseudohypoparathyroidism Variants.

Authors:  Harald Jüppner
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

Review 10.  Epidemiology and Diagnosis of Hypoparathyroidism.

Authors:  Bart L Clarke; Edward M Brown; Michael T Collins; Harald Jüppner; Peter Lakatos; Michael A Levine; Michael M Mannstadt; John P Bilezikian; Anatoly F Romanischen; Rajesh V Thakker
Journal:  J Clin Endocrinol Metab       Date:  2016-03-04       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.